These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 26989091)
1. Lung inflammation stalls Th17-cell migration en route to the central nervous system during the development of experimental autoimmune encephalomyelitis. Kanayama M; Danzaki K; He YW; Shinohara ML Int Immunol; 2016 Sep; 28(9):463-9. PubMed ID: 26989091 [TBL] [Abstract][Full Text] [Related]
2. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung. Glenn JD; Liu C; Whartenby KA J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897 [TBL] [Abstract][Full Text] [Related]
3. Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells. Gao Q; Zhang Y; Han C; Hu X; Zhang H; Xu X; Tian J; Liu Y; Ding Y; Liu J; Wang C; Guo Z; Yang Y; Cao X J Autoimmun; 2016 May; 69():74-85. PubMed ID: 26994903 [TBL] [Abstract][Full Text] [Related]
4. Remote control of T Vijitha N; Engel DR J Leukoc Biol; 2019 May; 105(5):827-828. PubMed ID: 30958568 [TBL] [Abstract][Full Text] [Related]
6. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850 [TBL] [Abstract][Full Text] [Related]
7. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235 [TBL] [Abstract][Full Text] [Related]
8. Sialomucin CD43 regulates T helper type 17 cell intercellular adhesion molecule 1 dependent adhesion, apical migration and transendothelial migration. Velázquez FE; Anastasiou M; Carrillo-Salinas FJ; Ngwenyama N; Salvador AM; Nevers T; Alcaide P Immunology; 2019 May; 157(1):52-69. PubMed ID: 30690734 [TBL] [Abstract][Full Text] [Related]
9. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis. Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436 [TBL] [Abstract][Full Text] [Related]
10. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells. Chung CY; Liao F J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264 [TBL] [Abstract][Full Text] [Related]
11. Contribution of LTi and T Schropp V; Rohde J; Rovituso DM; Jabari S; Bharti R; Kuerten S J Neuroinflammation; 2019 May; 16(1):111. PubMed ID: 31138214 [TBL] [Abstract][Full Text] [Related]
12. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis. Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780 [TBL] [Abstract][Full Text] [Related]
13. T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells. Ma J; McCarl CA; Khalil S; Lüthy K; Feske S Eur J Immunol; 2010 Nov; 40(11):3028-42. PubMed ID: 21061435 [TBL] [Abstract][Full Text] [Related]
14. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Jadidi-Niaragh F; Mirshafiey A Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381 [TBL] [Abstract][Full Text] [Related]
15. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments. Luchtman DW; Ellwardt E; Larochelle C; Zipp F Cytokine Growth Factor Rev; 2014 Aug; 25(4):403-13. PubMed ID: 25153998 [TBL] [Abstract][Full Text] [Related]
16. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice. Satoorian T; Li B; Tang X; Xiao J; Xing W; Shi W; Lau KH; Baylink DJ; Qin X Immunology; 2016 Aug; 148(4):326-38. PubMed ID: 27083389 [TBL] [Abstract][Full Text] [Related]
18. The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice. Takada I; Yogiashi Y; Makishima M Immunobiology; 2016 Feb; 221(2):188-92. PubMed ID: 26386981 [TBL] [Abstract][Full Text] [Related]
19. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway. Herold M; Posevitz V; Chudyka D; Hucke S; Groß C; Kurth F; Leder C; Loser K; Kurts C; Knolle P; Klotz L; Wiendl H J Immunol; 2015 Oct; 195(8):3584-95. PubMed ID: 26378076 [TBL] [Abstract][Full Text] [Related]
20. The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis. Sosa RA; Forsthuber TG J Interferon Cytokine Res; 2011 Oct; 31(10):753-68. PubMed ID: 21919736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]